Cart
sales@molnova.com
RBN013209
CAS No. 2597933-17-8
RBN013209 ( —— )
Catalog No. M28545 CAS No. 2597933-17-8
RBN013209 is a potent CD38 inhibitor. RBN013209 is useful in the treatment of cancer.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 2MG | 88 | Get Quote |
|
| 5MG | 149 | Get Quote |
|
| 10MG | 231 | Get Quote |
|
| 25MG | 446 | Get Quote |
|
| 50MG | 623 | Get Quote |
|
| 100MG | 880 | Get Quote |
|
| 200MG | Get Quote | Get Quote |
|
| 500MG | Get Quote | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameRBN013209
-
NoteResearch use only, not for human use.
-
Brief DescriptionRBN013209 is a potent CD38 inhibitor. RBN013209 is useful in the treatment of cancer.
-
DescriptionRBN013209 is a potent CD38 inhibitor. RBN013209 is useful in the treatment of cancer.
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
RecptorcPLA2α;Human Endogenous Metabolite
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number2597933-17-8
-
Formula Weight384.4
-
Molecular FormulaC19H24N6O3
-
Purity>98% (HPLC)
-
Solubility——
-
SMILES——
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Nakamura H, et al. Inhibition of arachidonic acid release and cytosolic phospholipase A2 alpha activity by D-erythro-sphingosine. Eur J Pharmacol. 2004 Jan 19;484(1):9-17.
molnova catalog
related products
-
CGGRGD TFA (1260223-...
CGGRGD TFA is synthesized via solid-phase peptide synthesis technique and the surface of PCL fibers is aminolysised by amino 2-cyanobenzothiazole followed by the addition of 2-cyanobenzothiazole (CBT).
-
Oleuropein
Oleuropein is an antioxidant polyphenol isolated from olive leaf.
-
Methyl2-(methylamino...
Methyl2-(methylamino)benzoate is anatural product.
